JP2024529119A5 - - Google Patents
Info
- Publication number
- JP2024529119A5 JP2024529119A5 JP2024508417A JP2024508417A JP2024529119A5 JP 2024529119 A5 JP2024529119 A5 JP 2024529119A5 JP 2024508417 A JP2024508417 A JP 2024508417A JP 2024508417 A JP2024508417 A JP 2024508417A JP 2024529119 A5 JP2024529119 A5 JP 2024529119A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- seq
- polypeptide
- polypeptide chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110932078 | 2021-08-13 | ||
| CN202110932078.7 | 2021-08-13 | ||
| PCT/CN2022/111717 WO2023016516A1 (zh) | 2021-08-13 | 2022-08-11 | 抗vegf a和vegf c双特异性抗体及其用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024529119A JP2024529119A (ja) | 2024-08-01 |
| JP2024529119A5 true JP2024529119A5 (https=) | 2025-08-15 |
Family
ID=85200580
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024508417A Pending JP2024529119A (ja) | 2021-08-13 | 2022-08-11 | 抗ｖｅｇｆａとｖｅｇｆｃ二重特異性抗体およびその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250002570A1 (https=) |
| EP (1) | EP4386004A4 (https=) |
| JP (1) | JP2024529119A (https=) |
| CN (1) | CN118043350A (https=) |
| AU (1) | AU2022327397A1 (https=) |
| CA (1) | CA3229250A1 (https=) |
| WO (1) | WO2023016516A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4663202A1 (en) * | 2023-02-10 | 2025-12-17 | Innovent Biologics (Suzhou) Co., Ltd. | Pharmaceutical preparation containing anti-vegfa and anti-vegfc bispecific binding protein |
| WO2025250739A1 (en) * | 2024-05-31 | 2025-12-04 | Janssen Biotech, Inc. | Chimeric antigen receptor with spacer domains derived from human igg |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6403088B1 (en) * | 1995-08-01 | 2002-06-11 | Helsinki University Licensing, Ltd. | Antibodies reactive with VEGF-C, a ligand for the Flt4 receptor tyrosine kinase (VEGFR-3) |
| KR100816621B1 (ko) | 1997-04-07 | 2008-03-24 | 제넨테크, 인크. | 항-ｖｅｇｆ 항체 |
| WO2011071577A1 (en) * | 2009-12-11 | 2011-06-16 | Genentech, Inc. | Anti-vegf-c antibodies and methods using same |
| EP2558122A4 (en) * | 2010-04-15 | 2014-03-05 | Vegenics Pty Ltd | COMBINATION TREATMENT WITH VEGF-C ANTAGONISTS |
| US20120225081A1 (en) * | 2010-09-03 | 2012-09-06 | Boehringer Ingelheim International Gmbh | Vegf-binding molecules |
| US9527925B2 (en) * | 2011-04-01 | 2016-12-27 | Boehringer Ingelheim International Gmbh | Bispecific binding molecules binding to VEGF and ANG2 |
| JP5987057B2 (ja) * | 2011-07-27 | 2016-09-06 | グラクソ グループ リミテッドＧｌａｘｏ Ｇｒｏｕｐ Ｌｉｍｉｔｅｄ | Ｆｃドメインと融合した抗ｖｅｇｆ単一可変ドメイン |
| KR102131370B1 (ko) * | 2013-10-18 | 2020-07-08 | 삼성전자주식회사 | Vegf-c에 특이적으로 결합하는 폴리펩타이드 및 그의 용도 |
| WO2016172485A2 (en) * | 2015-04-24 | 2016-10-27 | Genentech, Inc. | Multispecific antigen-binding proteins |
| CN108640994A (zh) * | 2018-06-28 | 2018-10-12 | 浙江众意生物科技有限公司 | 一种vegf-c单克隆抗体及试剂盒 |
| CN112961250B (zh) * | 2021-03-01 | 2023-06-06 | 长春金赛药业有限责任公司 | 抗体融合蛋白及其应用 |
-
2022
- 2022-08-11 CN CN202280055810.XA patent/CN118043350A/zh active Pending
- 2022-08-11 AU AU2022327397A patent/AU2022327397A1/en active Pending
- 2022-08-11 WO PCT/CN2022/111717 patent/WO2023016516A1/zh not_active Ceased
- 2022-08-11 EP EP22855496.0A patent/EP4386004A4/en active Pending
- 2022-08-11 CA CA3229250A patent/CA3229250A1/en active Pending
- 2022-08-11 JP JP2024508417A patent/JP2024529119A/ja active Pending
- 2022-08-11 US US18/681,904 patent/US20250002570A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2022241522B2 (en) | Bispecific antibody to a-syn/igf1r and use thereof | |
| US9441040B2 (en) | Antagonist antibodies and their fab fragments against GPVI and uses thereof | |
| EP2050764A1 (en) | Novel polyvalent bispecific antibody format and uses thereof | |
| JP6608698B2 (ja) | Ｐ２ｘ７受容体アンタゴニスト及びアゴニスト | |
| US20220185875A1 (en) | Bispecific antibody specifically bound to vegf and ang2 | |
| JP2019533719A5 (https=) | ||
| JP2021528973A5 (https=) | ||
| AU2023202595B2 (en) | BISPECIFIC ANTIBODY AGAINST a-SYN/IGF1R AND USE THEREOF | |
| JP2024001073A5 (https=) | ||
| CA3208455A1 (en) | Novel anti-gremlin1 antibodies | |
| JP2023548529A5 (https=) | ||
| JP2022521305A (ja) | 抗ｐｄ－ｌ１抗体及びその使用 | |
| JP2024529119A5 (https=) | ||
| WO2019080909A1 (en) | TARGETING THERAPEUTIC ANTIBODY RANKL | |
| CN113135995A (zh) | 抗her3单克隆抗体及其应用 | |
| JP2023539453A (ja) | Ｂｃｍａと結合する単一可変ドメイン及び抗原結合分子 | |
| JP2023519620A (ja) | Ｃｄ４７に結合する抗原結合ポリペプチド及び用途 | |
| JP7808831B2 (ja) | 抗ｃｄ２６抗体とその応用 | |
| WO2025103451A1 (zh) | Trgv9结合蛋白及其医药用途 | |
| WO2025172587A1 (en) | Binding constructs | |
| IL322879A (en) | Multispecific antibodies against 3CD and methods of use | |
| WO2026044000A1 (en) | Multispecific antibodies and methods of use thereof | |
| IL322877A (en) | Multispecific antibodies against 6cldn and 3cd and methods of use |